These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Salmon calcitonin in supportive therapy of neoplastic osteolysis. Preliminary report on a case of myeloma]. Andriani A, Beni A, Beni RA, Calistri A, Gelli GF. Clin Ter; 1981 Jan 31; 96(2):183-91. PubMed ID: 7237953 [No Abstract] [Full Text] [Related]
4. [Synthetic salmon calcitonin in the therapeutic management of osteolytic metastases of breast carcinoma]. Simone C, Racanelli A. Clin Ter; 1981 Aug 15; 98(3):247-67. PubMed ID: 7285537 [No Abstract] [Full Text] [Related]
6. Multiple myeloma: optimal use of salmon calcitonin in the management of myeloma osteoclastic bone disease. Bataille R, Tenoudji-Cohen M, Rossi JF. Br J Haematol; 1983 Jan 15; 53(1):170-1. PubMed ID: 6848121 [No Abstract] [Full Text] [Related]
7. Agents affecting osteolysis in patients with breast cancer. Coombes RC, Neville AM, Gazet JC, Ford HT, Nash AG, Baker JW, Powles JT. Cancer Chemother Pharmacol; 1979 Jan 15; 3(1):41-4. PubMed ID: 161206 [No Abstract] [Full Text] [Related]
8. [Biphosphonates. Contribution to the treatment of malignant osteolysis]. Prier A. Presse Med; 1979 Jan 15; 21(25):1143-5. PubMed ID: 1409460 [No Abstract] [Full Text] [Related]
10. An electron microscopic investigation of human familial bone dysplasia. Inhibition of osteocytic osteolysis and induction of osteocytic formation of elastic fibers following calcitonin treatment. Nunez EA, Horwith M, Krook L, Whalen JP. Am J Pathol; 1979 Jan 15; 94(1):1-18. PubMed ID: 760539 [Abstract] [Full Text] [Related]
11. Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.). van Breukelen FJ, Bijvoet OL, van Oosterom AT. Lancet; 1979 Apr 14; 1(8120):803-5. PubMed ID: 86043 [Abstract] [Full Text] [Related]
12. [The extratumor mechanisms of osteolysis in multiple myeloma and the means for their correction]. Golenkov AK, Lutskaia TD, Kliushnenkova EN, Tishenina RS, Valiulina LS, Novikov VE, Mitina TA. Ter Arkh; 1996 Apr 14; 68(7):58-61. PubMed ID: 8928074 [Abstract] [Full Text] [Related]
13. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia. Sekine M, Takami H. Oncol Rep; 1998 Apr 14; 5(1):197-9. PubMed ID: 9458321 [Abstract] [Full Text] [Related]
14. [Reconstruction of metastatically destroyed skeletal parts following radiologic-cytostatic-hormonal and orthopaedic therapy (author's transl)]. Barndt J. Radiobiol Radiother (Berl); 1977 Apr 14; 18(5):619-24. PubMed ID: 609725 [No Abstract] [Full Text] [Related]
15. [Clinical experience with human calcitonin]. De Bastiani G, Nogarin L, Lazzaretto R. Minerva Med; 1981 Jun 30; 72(26):1719-23. PubMed ID: 6166901 [Abstract] [Full Text] [Related]
16. The potential role of bisphosphonates in prostate cancer. Oades GM, Coxon J, Colston KW. Prostate Cancer Prostatic Dis; 2002 Jun 30; 5(4):264-72. PubMed ID: 12627210 [Abstract] [Full Text] [Related]
17. [Use of calcitonin in neoplastic osteolysis]. Pastorino G, Bianucci M. Minerva Med; 1983 Mar 31; 74(13):707-14. PubMed ID: 6835560 [Abstract] [Full Text] [Related]
18. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma. Bataille R, Chappard D, Klein B. Int J Clin Lab Res; 1992 Mar 31; 21(4):283-7. PubMed ID: 1591381 [Abstract] [Full Text] [Related]
19. A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Body JJ, Greipp P, Coleman RE, Facon T, Geurs F, Fermand JP, Harousseau JL, Lipton A, Mariette X, Williams CD, Nakanishi A, Holloway D, Martin SW, Dunstan CR, Bekker PJ. Cancer; 2003 Feb 01; 97(3 Suppl):887-92. PubMed ID: 12548591 [Abstract] [Full Text] [Related]
20. [Medullary compressions caused by epidural metastases. (Indications for surgical treatment)]. Sanguinetti C. Chir Patol Sper; 1969 Feb 01; 17(1):29-49. PubMed ID: 5282551 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]